Prostate Cancer - Results from #23040

Can high-spatial resolution T2-weighted endorectal MRI rule out clinically significant prostate cancer? - Abstract July 24, 2013

Treatment effects in prostate cancer following traditional and emerging therapies - Abstract July 24, 2013

Prognostic utility of cell cycle progression score in men with prostate cancer after primary external beam radiation therapy - Abstract July 24, 2013

Couple distress after localised prostate cancer - Abstract July 24, 2013

Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard - Abstract July 24, 2013

Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis - Abstract July 24, 2013

Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial - Abstract July 23, 2013

Patient selection and pathological outcomes using currently available active surveillance criteria - Abstract July 23, 2013

Multifield optimization intensity-modulated proton therapy (MFO-IMPT) for prostate cancer: Robustness analysis through simulation of rotational and translational alignment errors - Abstract July 23, 2013

Factors associated with adherence to physical activity guidelines in patients with prostate cancer - Abstract July 23, 2013

Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial - Abstract July 23, 2013

Assessment of prostate cancer aggressiveness using dynamic contrast-enhanced magnetic resonance imaging at 3 T - Abstract July 23, 2013

Prostate radiotherapy clinical trial quality assurance: How real should real time review be? (A TROG-OCOG Intergroup Project) - Abstract July 23, 2013

Serum total testosterone is a significant preoperative variable independently contributing to separating the prostate cancer population into prostatectomy Gleason score groups - Abstract July 23, 2013

Prostate cancer progression after androgen deprivation therapy: Mechanisms of castrate resistance and novel therapeutic approaches - Abstract July 23, 2013

Ultraviolet index and racial differences in prostate cancer incidence and mortality - Abstract July 22, 2013

Endurance training in prostate cancer patients treated with androgen deprivation therapy - Abstract July 22, 2013

Prostate tissue characterization/classification in 144 patient population using wavelet and higher order spectra features from transrectal ultrasound images - Abstract July 22, 2013

Serum prostate-specific antigen (PSA) concentration is positively associated with rate of disease reclassification on subsequent active surveillance prostate biopsy in men with low PSA density - Abstract July 22, 2013

Spatial distribution of positive cores improves the selection of patients with low-risk prostate cancer as candidates for active surveillance - Abstract July 22, 2013

Page 1153 of 1454